The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions
Open accessAbstract
had no impact on blood counts or indices. Mutational burden of both genes correlated with X-inactivation skewing but no significant association with age-adjusted telomere length reduction was documented. The discordance between the high prevalence of mutations in these 2 genes and their limited biological impact raise the question of the potential role of dysregulated epigenetic modifiers in normal aging hematopoiesis, which may include support to failing hematopoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various other systemic effects have been described in association with CH, including chronic obstructive pulmonary disease and other pulmonary disease [16,33,34]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function heterozygous mutations in epigenetic regulators DNMT3A (cytosine methyltransferase) and TET2 (methylcytosine dioxygenase) are the most frequently detected mutations in CHIP, accounting for about 50% to 60% and 10% to 30% of mutations found in CHIP carriers, respectively.1, 2, 3,7,8”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of CHIP, TET2 mutations show highest clonal expansion rates over time (with an estimated 10% annual growth rate compared with 5% of DNMT3A mutations7,8,10).”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function heterozygous mutations in epigenetic regulators DNMT3A (cytosine methyltransferase) and TET2 (methylcytosine dioxygenase) are the most frequently detected mutations in CHIP, accounting for about 50% to 60% and 10% to 30% of mutations found in CHIP carriers, respectively.1, 2, 3,7,8”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“are predicted to have high expansion rates (10% increase in mean VAF per year1, 2, 3,7)”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“many have noted that DNMT3A mutations confer little phenotype on steady state hematopoiesis (Buscarlet et al., 2017)”
From Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling (2021) · cites this paper as Buscarlet et al., 2017
In the citing paper
“CHIP itself does not denote a malignancy, nor is it associated with clinically significant alterations in blood counts 28,63.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
In the citing paper
“Other studies have found links between CHIP and chronic obstructive pulmonary disease (COPD) 37,63.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
In the citing paper
“However, CHIP was also strongly linked to smoking in these studies, so the result could be confounded by this association.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Telomere measurement by quantitative PCR
Cawthon, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,550
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Cited by
Sorted by citations
Items 101–200 of 381
Ortmann, C. A., Dorsheimer, L., Abou‐El‐Ardat, K., Hoffrichter, J., Aßmus, B., Bonig, H. B., Scholz, A., Pfeifer, H., Martin, H., Schmid, T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.064 · Cited by 61
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs
Hosseini, M., Voisin, V., Chegini, A., Varesi, A., Cathelin, S., Ayyathan, D. M., Liu, A. C. H., Yang, Y., Wang, V. Y., Maher, A., et al. (2025) · Nature · doi:10.1038/s41586-025-08871-w · Cited by 70
Clonal Hematopoiesis: From Mechanisms to Clinical Intervention
Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 63
Schoeler, K., Aufschnaiter, A., Messner, S., Derudder, E., Herzog, S., Villunger, A., Rajewsky, K., & Labi, V. (2019) · FEBS Journal · doi:10.1111/febs.14934 · Cited by 59
The paradox of cancer genes in non-malignant conditions: implications for precision medicine
Adashek, J. J., Kato, S., Lippman, S. M., & Kurzrock, R. (2020) · Genome Medicine · doi:10.1186/s13073-020-0714-y · Cited by 59
Hematopoietic Stem Cells and the Immune System in Development and Aging
Shevyrev, D., Tereshchenko, V., Berezina, T. N., & Александрович, Р. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065862 · Cited by 58
Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality
Hansen, J. W., Pedersen, D. A., Larsen, L. A., Husby, S., Clemmensen, S. B., Hjelmborg, J., Favero, F., Weischenfeldt, J., Christensen, K., & Grønbæk, K. (2019) · Blood · doi:10.1182/blood.2019001793 · Cited by 53
Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia
Corces, M. R., Chang, H. Y., & Majeti, R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00263 · Cited by 56
Stecklein, S. R., Kimler, B. F., Yoder, R., Schwensen, K., Staley, J. M., Khan, Q. J., O’Dea, A. P., Nye, L. E., Elia, M., Heldstab, J., et al. (2023) · npj Breast Cancer · doi:10.1038/s41523-023-00512-7 · Cited by 48
Immunomodulation and immunopharmacology in heart failure
Markousis‐Mavrogenis, G., Baumhove, L., Al‐Mubarak, A. A., Aboumsallem, J. P., Bömer, N., Voors, A. A., & van der Meer, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00919-6 · Cited by 51
Grimm, J., Bill, M., Jentzsch, M., Beinicke, S., Häntschel, J., Goldmann, K., Schulz, J. C., Cross, M. A., Franke, G., Behre, G., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0413-0 · Cited by 46
Clonal hematopoiesis: Pre-cancer PLUS
Silver, A. J., & Jaiswal, S. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.003 · Cited by 46
What To Tell Your Patient With Clonal Hematopoiesis And Why: Insights From Two Specialized Clinics
Steensma, D. P., & Bolton, K. L. (2020) · Blood · doi:10.1182/blood.2019004291 · Cited by 45
Molecular pathogenesis of acquired aplastic anemia
Boddu, P. C., & Kadia, T. M. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13182 · Cited by 44
Concordance for clonal hematopoiesis is limited in elderly twins
Fabre, M. A., McKerrell, T., Zwiebel, M., Vijayabaskar, M. S., Park, N., Wells, P. M., Rad, R., Deloukas, P., Small, K. S., Steves, C. J., et al. (2019) · Blood · doi:10.1182/blood.2019001807 · Cited by 43
Somatic Variants: New Kids on the Block in Human Immunogenetics
Horebeek, L. V., Dubois, B., & Goris, A. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.09.005 · Cited by 46
Stem cell donors should be screened for CHIP
Dezern, A. E., & Gondek, L. P. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000394 · Cited by 41
Immunometabolic control of hematopoiesis
Hajishengallis, G., Li, X., & Chavakis, T. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100923 · Cited by 43
Clonal hematopoiesis: Molecular and clinical implications
Kusne, Y. N., Xie, Z., & Patnaik, M. M. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106787 · Cited by 43
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients
Panagiota, V., Kerschbaum, J. F., Penack, O., Stein, C. M., Arends, C. M., Koenecke, C., Strzelecka, P. M., Kloos, A., Wiegand, L., Lasch, A., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000957 · Cited by 44
Hematopoietic Stem Cells and Their Niche in Bone Marrow
Kwon, M., Kim, B. S., Yoon, S., Oh, S., & Lee, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136837 · Cited by 42
Clonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications
Hartmann, L., & Metzeler, K. H. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22756 · Cited by 42
Shin, T., Zhou, Y., Chen, S., Cordes, S., Grice, M. Z., Fan, X., Lee, B., Aljanahi, A. A., Hong, S. G., Vaughan, K. L., et al. (2022) · Blood · doi:10.1182/blood.2021014875 · Cited by 39
Gorica, E., Mohammed, S. A., Ambrosini, S., Calderone, V., Costantino, S., & Paneni, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.923014 · Cited by 39
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia
Awad, S. A., Kankainen, M., & Mustjoki, S. M. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1894652 · Cited by 39
Calibration-free NGS quantitation of mutations below 0.01% VAF
Dai, P., Wu, L. R., Chen, S. X., Wang, M., Cheng, L. Y., Zhang, J. X., Hao, P., Yao, W., Zarka, J. G., Issa, G. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26308-6 · Cited by 37
Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer
Prasad, R. M., Yen, T. J., & Bellacosa, A. (2020) · Advanced Genetics · doi:10.1002/ggn2.10033 · Cited by 39
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
Oñate, G., Bataller, Á., Garrido, A., Hoyos, M., Arnán, M., Vives, S., Coll, R., Tormo, M., Sampol, A., Escoda, L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004136 · Cited by 37
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
Stein, A., Metzeler, K. H., Kubasch, A. S., Rommel, K., Desch, S., Buttner, P. G., Rosołowski, M., Cross, M. A., Platzbecker, U., & Thiele, H. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00969-w · Cited by 40
Cattaneo, D., Croci, G. A., Bucelli, C., Tabano, S. M., Cannone, M. G., Gaudioso, G., Barbanti, M. C., Barbullushi, K., Bianchi, P. I., Fermo, E., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.637116 · Cited by 36
Transcriptional networks in acute myeloid leukemia
Thoms, J. A. I., Beck, D., & Pimanda, J. E. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22794 · Cited by 33
Ayachi, S., Buscarlet, M., & Busque, L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.008 · Cited by 32
Role of reactive oxygen species in myelodysplastic syndromes
Jing, Q., Zhou, C., Zhang, J., Zhang, P., Wu, Y., Zhou, J., Tong, X., Li, Y., Du, J., & Wang, Y. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00570-0 · Cited by 33
Clonal Hematopoiesis and risk of Acute Myeloid Leukemia
Desai, P. M., Hassane, D. C., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.05.007 · Cited by 36
Mesenchymal stromal cell senescence in haematological malignancies
Plakhova, N., Panagopoulos, V., Vandyke, K., Zannettino, A. C. W., & Mrozik, K. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10069-9 · Cited by 33
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Duployez, N., Demonchy, J., Berthon, C., Goutay, J., Caplan, M., Moreau, A.-S., Bignon, A. L., Marceau‐Renaut, A., Garrigue, D., Raczkiewicz, I., et al. (2020) · Cancers · doi:10.3390/cancers12071992 · Cited by 31
Pizzi, M., Croci, G. A., Ruggeri, M., Tabano, S. M., Tos, A. P. D., Sabattini, E., & Gianelli, U. (2021) · Cancers · doi:10.3390/cancers13225666 · Cited by 36
Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface
Buttigieg, M. M., & Rauh, M. J. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00132 · Cited by 30
Inflammageing and clonal haematopoiesis interplay and their impact on human disease
Hajishengallis, G., & Chavakis, T. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00936-y · Cited by 37
Denicolò, S., Vogi, V., Keller, F., Thöni, S., Eder, S., Heerspink, H. J. L., Rosivall, L., Więcek, A., Mark, P. B., Perco, P., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.01.1064 · Cited by 30
Jawad, M. D., Afkhami, M., Ding, Y., Zhang, X., Li, P., Young, K., Xu, M. L., Cui, W., Zhao, Y., Halene, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.849376 · Cited by 29
Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations
Jakubek, Y. A., Reiner, A. P., & Honigberg, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.11.009 · Cited by 30
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
Feng, Y., Yuan, Q., Newsome, R. C., Robinson, T. M., Bowman, R. L., Zuniga, A. N., Hall, K. N., Bernsten, C. M., Shabashvili, D. E., Krajcik, K. I., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230011 · Cited by 30
Somatic mutations in autoinflammatory and autoimmune disease
Torreggiani, S., Castellan, F. S., Aksentijevich, I. A., & Beck, D. B. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01168-8 · Cited by 30
Mengel‐From, J., Lindahl‐Jacobsen, R., Nygaard, M., Soerensen, M., Ørstavik, K. H., Hertz, J. M., Andersen‐Ranberg, K., Tan, Q., & Christensen, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-83702-2 · Cited by 29
Ramabadran, R., Wang, J. H., Reyes, J. M., Guzman, A. G., Gupta, S., Rosas, C., Brunetti, L., Gundry, M. C., Tovy, A., Long, H., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01109-9 · Cited by 33
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
Kjær, L. (2020) · Cancers · doi:10.3390/cancers12082100 · Cited by 30
Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID‐19
Hameister, E., Stolz, S. M., Fuhrer, Y., Thienemann, F., Schaer, D. J., Nemeth, J., Schuepbach, R. A., Goede, J. S., Reinhart, S., Schmidt, A. E., et al. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000453 · Cited by 28
Pegliasco, J., Hirsch, P., Marzac, C., Isnard, F., Meniane, J.-C., Deswarte, C., Pellet, P., Lemaitre, C., Leroy, G., Moraes, G. R., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01319-w · Cited by 27
Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease
Wang, Y., Sano, S., Ogawa, H., Horitani, K., Evans, M. A., Yura, Y., Miura‐Yura, E., Doviak, H., & Walsh, K. X. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab215 · Cited by 26
TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights
Gao, Q., Shen, K., & Xiao, M. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01771-2 · Cited by 35
Nowakowska, M. K., Kim, T., Thompson, M. T., Bolton, K. L., Deswal, A., Lin, S. H., Scheet, P. A., Wehner, M. R., & Nead, K. T. (2022) · American Journal of Hematology · doi:10.1002/ajh.26465 · Cited by 28
Naqvi, K., Sasaki, K., Bravo, G. M., Piérola, A. A., Yilmaz, M. E., Short, N. J., Assi, R. E., Jabbour, E. J., Ravandi, F., Kadia, T. M., et al. (2019) · Cancer · doi:10.1002/cncr.32056 · Cited by 28
Somatic mutations and T-cell clonality in patients with immunodeficiency
Savola, P., Martelius, T., Kankainen, M., Huuhtanen, J., Lundgren, S., Koski, Y., Eldfors, S., Kelkka, T., Keränen, M. A. I., Ellonen, P., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.220889 · Cited by 25
Buccisano, F., Dillon, R. J., Freeman, S. D., & Venditti, A. (2018) · Cancers · doi:10.3390/cancers10070215 · Cited by 25
Dawoud, A. A. Z., Tapper, W., & Cross, N. C. P. (2023) · Science Advances · doi:10.1126/sciadv.ade9746 · Cited by 26
Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities
Vatapalli, R. J., Rossi, A. P., Chan, H. M., & Zhang, J. (2024) · Epigenomics · doi:10.1080/17501911.2024.2430169 · Cited by 28
Emerging T-cell lymphomas after CAR T-cell therapy
Braun, T., Kuschel, F., Reiche, K., Merz, M., & Herling, M. (2025) · Leukemia · doi:10.1038/s41375-025-02574-x · Cited by 27
Epigenetic and transcriptional control of mast cell responses
Monticelli, S., & Leoni, C. (2017) · F1000Research · doi:10.12688/f1000research.12384.1 · Cited by 24
Dorsheimer, L., Aßmus, B., Rasper, T., Ortmann, C. A., Abou‐El‐Ardat, K., Kiefer, K. C., Hoffmann, J., Seeger, F. H., Bonig, H. B., Dimmeler, S., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.224402 · Cited by 24
Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
Palomo, L., Acha, P., & Solé, F. G. (2021) · Cancers · doi:10.3390/cancers13092120 · Cited by 24
Evolutionary trajectory of leukemic clones and its clinical implications
Tuval, A., & Shlush, L. I. (2019) · Haematologica · doi:10.3324/haematol.2018.195289 · Cited by 28
Kwee, S. A., & Tiirikainen, M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.124 · Cited by 24
Hoermann, G., Greiner, G., Griesmacher, A., & Valent, P. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030094 · Cited by 23
A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease
Moll, M. R., Jackson, V. E., Yu, B., Grove, M. L., London, S. J., Gharib, S. A., Bartz, T. M., Sitlani, C. M., Dupuis, J., O’Connor, G. T., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2021 · Cited by 22
Amorós-Pérez, M., & Fuster, J. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.008 · Cited by 24
Goldman, E. A., Spellman, P. T., & Agarwal, A. (2023) · Molecular Case Studies · doi:10.1101/mcs.a006251 · Cited by 25
Mian, S. A., & Bonnet, D. A. (2021) · Cancers · doi:10.3390/cancers13164116 · Cited by 22
CHIPing away the progression potential of CHIP: A new reality in the making
Xie, Z., & Zeidan, A. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.101001 · Cited by 22
Somatic Mutations in Aplastic Anemia
Mufti, G. J., & Marsh, J. C. W. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.03.002 · Cited by 21
Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice
Lee, J., Godfrey, A. L., & Nangalia, J. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100708 · Cited by 21
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
Christen, F., Hablesreiter, R., Hoyer, K., Hennch, C., Maluck-Böttcher, A., Segler, A., Madadi, A., Frick, M., Bullinger, L., Briest, F., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01469-x · Cited by 22
Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications
Nathan, D. I., Dougherty, M. L., Bhatta, M., Mascarenhas, J. O., & Marcellino, B. K. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104187 · Cited by 22
The impact of age and number of mutations on the size of clonal hematopoiesis
Wang, K., Zhang, W., Yi, L., Zhao, M., Li, P.-Y., Fu, M.-H., Lin, R., Zhu, Y., Li, J., Yang, W., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319364121 · Cited by 24
Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion
Quin, C., DeJong, E. N., McNaughton, A. J. M., Buttigieg, M. M., Basrai, S., Abelson, S., LARCHÉ, M. J., Rauh, M. J., & Bowdish, D. M. E. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011833 · Cited by 20
Decoy fitness peaks, tumor suppression, and aging
Higa, K. C., & DeGregori, J. V. (2019) · Aging Cell · doi:10.1111/acel.12938 · Cited by 19
Causes of Clonal Hematopoiesis: a Review
Joo, L., Bradley, C. C., Lin, S. H., Scheet, P. A., & Nead, K. T. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01362-z · Cited by 23
Franch‐Expósito, S., Mehine, M. M., Ptashkin, R. N., Bolton, K. L., Bandlamudi, C., Srinivasan, P., Zhang, L., Goodell, M. A., Gedvilaite, E., Menghrajani, K. N., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00070 · Cited by 21
Shi, Y., Huang, X., Zeng, Y., Zhai, M., Yao, H., Liu, C., Li, B., Gong, S., Yu, Q., Zhuang, J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103013 · Cited by 21
Clonal Hematopoiesis and Premalignant DiseasesPreprint
Kaner, J. D., Desai, P. M., Mencia-Trinchant, N., Guzmán, M. L., Roboz, G. J., & Hassane, D. C. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035675 · Cited by 20
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
Veiga, C. B., Lawrence, E., Murphy, A. J., Herold, M. J., & Dragoljevic, D. (2021) · Cancers · doi:10.3390/cancers13081968 · Cited by 20
Clonal hematopoiesis and autoimmunity
Kishtagari, A., Corty, R. W., & Visconte, V. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.01.012 · Cited by 23
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
Kandarakov, O. F., & Belyavsky, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217902 · Cited by 22
Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia
Steensma, D. P., & Ebert, B. L. (2018) · New England Journal of Medicine · doi:10.1056/nejme1802610 · Cited by 19
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
Lassalle, F., Duployez, N., Vincent, F., Rauch, A., Denimal, T., Rosa, M., Labreuche, J., Dombrowicz, D., Staels, B., Preudhomme, C., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.04.010 · Cited by 21
Role of Circulating Tumor DNA in Hematological Malignancy
Ogawa, M., Yokoyama, K., Imoto, S., & Tojo, A. (2021) · Cancers · doi:10.3390/cancers13092078 · Cited by 18
Demaree, B., Delley, C. L., Vasudevan, H. N., Peretz, C. A. C., Ruff, D., Smith, C. C., & Abate, A. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.26.967133 · Cited by 18
Newell, L. F., Dunlap, J. B., Gatter, K. M., Bagby, G. C., Press, R. D., Cook, R. J., Fletcher, L. B., Leonard, J. T., Leong, K., Bubalo, J. S., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16635 · Cited by 17
Camus, V., Viennot, M., Lévêque, É., Viailly, P., Tonnelet, D., Veresezan, E., Drieux, F., Etancelin, P., Dubois, S., Stamatoullas, A., et al. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.2010060 · Cited by 17
Inflammation and hematopoietic stem cells aging
He, H., & Wang, J. (2020) · Blood Science · doi:10.1097/bs9.0000000000000063 · Cited by 16
Sega, F. V. D., Palumbo, D., Fortini, F., D’Agostino, Y., Cimaglia, P., Marracino, L., Severi, P., Strianese, O., Tarallo, R., Nassa, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24130-8 · Cited by 20
Clonal approaches to understanding the impact of mutations on hematologic disease development
Nangalia, J., Mitchell, E., & Green, A. R. (2019) · Blood · doi:10.1182/blood-2018-11-835405 · Cited by 19
Treatment of Iron Deficiency in the Elderly
Auerbach, M., & Spivak, J. L. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.003 · Cited by 16
Petzer, V., Schwendinger, S., Haschka, D., Vogi, V., Tymoszuk, P., Burkert, F. R., Sahanic, S., Sonnweber, T., Bellmann‐Weiler, R., Löffler‐Ragg, J., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26251 · Cited by 16
Gaulin, C., Kelemen, K., & Yi, C. A. (2022) · Life · doi:10.3390/life12081135 · Cited by 16
Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
van Bladel, D. A. G., Stevens, W. B. C., van den Brand, M., Kroeze, L. I., Groenen, P. J. T. A., van Krieken, J. H., Hebeda, K. M., & Scheijen, B. (2022) · Cancers · doi:10.3390/cancers14133222 · Cited by 15
Huang, J., Xie, J., Wang, Y., Sheng, M., Sun, Y., Chen, P., Rong, S., Yin, D., Wang, Y., Zhu, P., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02542-5 · Cited by 16
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis
Brown, D. W., Zhou, W., Wang, Y., Jones, K. M., Luo, W., Dagnall, C. L., Teshome, K., Klein, A., Zhang, T., Lin, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32986-7 · Cited by 16
On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer
Park, M. D., Belabed, M., Chen, S. T., Hamon, P., Hegde, S., Mattiuz, R., Marron, T. U., & Mérad, M. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061521-085949 · Cited by 15
Isobe, T., Kuciński, I., Barile, M., Wang, X., Hannah, R., Bastos, H. P., Chabra, S., Vijayabaskar, M. S., Sturgess, K., Williams, M., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100426 · Cited by 15
Metadata
- Authors
- Buscarlet, M., Provost, S., Zada, Y. F., Barhdadi, A., Bourgoin, V., Lépine, G., Mollica, L., Szuber, N., Dubé, M.-P., & Busque, L.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Montreal Heart Institute (CA)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-08-10
- Volume
- 130
- Issue
- 6
- Pages
- 753-762
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2728241634
- Cited by
- 383
- References
- 50
- Citations by year
- 2026: 22 · 2025: 34 · 2024: 37 · 2023: 47 · 2022: 59 · 2021: 55 · 2020: 46 · 2019: 40 · 2018: 34 · 2017: 6
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Concordia University
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNMT3A, TET2, clonal hematopoiesis, somatic mutations, X-inactivation skewing, telomere length, epigenetic regulators, genetic susceptibility, mutational burden
- MeSH terms
- DNA Methyltransferase 3A, Age Factors, Aged, Aged, 80 and over, Aging, Blood Cell Count, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, Female, Hematopoiesis, Humans, Male, Middle Aged, Mutation, Proto-Oncogene Proteins, Cohort Studies, Hematologic Neoplasms, Genetic Predisposition to Disease, Dioxygenases, X Chromosome Inactivation, High-Throughput Nucleotide Sequencing, Telomere Homeostasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
